Report ID |
113317 |
Drug Identification Number |
02241114 |
Brand name |
AVANDIA |
Common or Proper name |
rosiglitazone (as rosiglitazone maleate) tablets |
Company Name |
GLAXOSMITHKLINE INC |
Market Status |
CANCELLED POST MARKET |
Active Ingredient(s) |
ROSIGLITAZONE |
Strength(s) |
8MG |
Dosage form(s) |
TABLET |
Route of administration |
ORAL
ORAL |
Packaging size |
60's |
ATC code |
A10BG |
ATC description |
BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for discontinuation |
Business reasons |
Anticipated discontinuation date |
|
Actual discontinuation date |
2020-04-22 |
Remaining supply date |
2019-09-30 |
Discontinuation status |
Discontinued |
Discontinuation decision reversal |
No |
Information on remaining supply |
|
Company comments |
|
Health Canada comments |
|
Company contact information |
1-800-387-7374 |